Clinical Trials Directory

Trials / Unknown

UnknownNCT03383068

Research of Intensive Metabolic Intervention Before Pregnancy in PCOS

Research of Intensive Metabolic Intervention Before Pregnancy in Polycystic Ovary Syndrome

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

To investigate whether intensive metabolic intervention of PCOS women before pregnancy can improve pregnancy outcome.Besides, the investigators aim to investigate the best therapy strategy of metabolic intervention before pregnancy.The investigators plan to recruit PCOS women at childbearing age. By using acarbose, GLP-1 analogue, berberin et al. the investigators will intervent the participants' metabolic statues for 3 months before pregnancy and to compare outcome in each group.

Detailed description

To investigate whether intensive metabolic intervention of PCOS women before pregnancy can improve pregnancy outcome.Besides, the investigators aim to investigate the best therapy strategy of metabolic intervention before pregnancy.The investigators plan to recruit PCOS women with IGR / DM not effective of metformin treatment at childbearing age. By using acarbose, GLP-1 analogue, berberin et al. the investigators will intervent the participants' metabolic statues for 3 months before pregnancy and to compare outcome in each group.

Conditions

Interventions

TypeNameDescription
DRUGAcarbose 100 MGfor metformin uneffective subjects, using acarbose for 3 months
DRUGExenatidefor metformin uneffective subjects, using Exenatide for 3 months
DRUGOrlistatfor metformin uneffective subjects, using Orlistatfor 3 months
DRUGMetforminmetformin effective subjects,act as control group

Timeline

Start date
2018-01-01
Primary completion
2018-12-31
Completion
2020-06-30
First posted
2017-12-26
Last updated
2017-12-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03383068. Inclusion in this directory is not an endorsement.